Heron Therapeutics Ownership | Who Owns Heron Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Heron Therapeutics Ownership Summary


Heron Therapeutics is owned by 27.95% institutional investors, 0.84% insiders, and 71.21% retail investors. Rubric capital management lp is the largest institutional shareholder, holding 17.64% of HRTX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.07% of its assets in Heron Therapeutics shares.

HRTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockHeron Therapeutics27.95%0.84%71.21%
SectorHealthcare Stocks 232.51%10.72%-143.22%
IndustryBiotech Stocks 384.55%10.58%-295.13%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rubric capital management lp30.05M17.64%$39.06M
Adage capital partners gp10.24M6.65%$12.90M
Clearline capital lp9.71M6.31%$12.24M
Blackrock funding, inc. /de10.22M6.00%$13.28M
Vanguard group9.82M5.76%$12.77M
Velan capital investment management lp8.75M5.68%$11.03M
Blackrock8.33M5.51%$29.14M
Palisade capital management, lp7.33M4.76%$9.23M
Tejara capital5.13M3.01%$6.67M
Baker bros. advisors lp4.25M2.76%$5.36M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Velan capital investment management lp8.75M10.36%$11.03M
Tejara capital5.13M1.57%$6.67M
Jw asset management3.67M1.55%$4.77M
Congress park capital3.07M1.19%$3.99M
Stonepine capital management850.10K0.87%$1.07M
Cm management750.00K0.82%$975.00K
Orchard capital management680.43K0.77%$884.56K
Clearline capital lp9.71M0.56%$12.24M
Richmond brothers572.12K0.47%$743.75K
Rubric capital management lp30.05M0.47%$39.06M

Top Buyers

HolderShares% AssetsChange
Clearline capital lp9.71M0.56%8.86M
Baker bros. advisors lp4.25M0.04%4.25M
Adage capital partners gp10.24M0.02%2.39M
Palisade capital management, lp7.33M0.25%2.24M
Velan capital investment management lp8.75M10.36%1.77M

Top Sellers

HolderShares% AssetsChange
Orbimed advisors---6.51M
Point72 asset management---4.78M
Aigh capital management---3.01M
Price t rowe associates inc /md/76.64K--2.81M
Citigroup3.48K--2.47M

New Positions

HolderShares% AssetsChangeValue
Baker bros. advisors lp4.25M0.04%4.25M$5.36M
Caption management734.30K0.01%734.30K$925.21K
Pale fire capital se471.19K0.07%471.19K$593.70K
Panagora asset management440.25K0.00%440.25K$572.33K
Group one trading145.17K0.00%145.17K$188.72K

Sold Out

HolderChange
Allspring global investments-1.00
Toronto dominion bank-9.00
Lindbrook capital-16.00
Mid-american wealth advisory group-24.00
Gps wealth strategies group-72.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202586-50.86%47,611,662-68.81%270.28%36-54.43%18-63.27%
Sep 30, 202590-45.78%46,256,389-62.08%300.48%31-63.10%27-18.18%
Jun 30, 20251742.35%131,460,8435.36%851.29%8714.47%34-26.09%
Mar 31, 20257-95.81%36,006,112-68.67%230.41%4-94.12%--100.00%
Dec 31, 202490-48.86%38,837,514-68.12%250.40%37-57.95%24-36.84%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF4.68M3.07%-
Vanguard Total Stock Mkt Idx Inv4.58M2.99%-101.04K
iShares Russell 2000 ETF3.74M2.44%-
Palisade Small Cap Core Equity3.19M2.09%-141.42K
Biotech Growth Ord2.58M1.70%2.58M
Franklin US Small Cap Growth Equity1.80M1.19%-
Vanguard Institutional Extnd Mkt Idx Tr1.55M1.01%-674.04K
Fidelity Small Cap Index1.54M1.00%339.16K
iShares Russell 2000 Value ETF1.18M0.77%-
State St Russell Sm/Mid Cp® Indx NL Cl C851.80K0.56%3.84K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 08, 2025Rubric Capital Management LP-Buy$3.58M
Aug 08, 2025Rubric Capital Management LP-Buy-
Aug 08, 2025Rubric Capital Management LP-Buy-
Aug 08, 2025Morgan Adam-Buy$105.02K
Aug 08, 2025Morgan Adam-Buy$2.65M

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q4--
2025 Q35-
2025 Q2--
2025 Q1--

HRTX Ownership FAQ


Who Owns Heron Therapeutics?

Heron Therapeutics shareholders are primarily institutional investors at 27.95%, followed by 0.84% insiders and 71.21% retail investors. The average institutional ownership in Heron Therapeutics's industry, Biotech Stocks , is 384.55%, which Heron Therapeutics falls below.

Who owns the most shares of Heron Therapeutics?

Heron Therapeutics’s largest shareholders are Rubric capital management lp (30.05M shares, 17.64%), Adage capital partners gp (10.24M shares, 6.65%), and Clearline capital lp (9.71M shares, 6.31%). Together, they hold 30.59% of Heron Therapeutics’s total shares outstanding.

Does Blackrock own Heron Therapeutics?

Yes, BlackRock owns 5.51% of Heron Therapeutics, totaling 8.33M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 29.14M$. In the last quarter, BlackRock increased its holdings by 1.04M shares, a 14.27% change.

Who is Heron Therapeutics’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Heron Therapeutics’s biggest shareholder by percentage of total assets invested, with 10.36% of its assets in 8.75M Heron Therapeutics shares, valued at 11.03M$.

Who is the top mutual fund holder of Heron Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Heron Therapeutics shares, with 3.07% of its total shares outstanding invested in 4.68M Heron Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools